SHIB Price Prediction; Analysts Debate WIF’s ATH Potential Amid Hype for New Crypto Lunex Network
FDA’s historic approval of PTSD study may boost cannabis sector down the road
FDA’s historic approval of PTSD study may boost cannabis sector down the road
The move marks a rare action by the FDA to sanction a study on cannabis despite the plant’s current Schedule I classification under federal law as a drug with no therapeutic use, in the same category as heroin and LSD.
